These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24140364)

  • 1. Response of dupuytren fibroblasts to different oxygen environments.
    Türker T; Murphy E; Kaufman CL; Kutz JE; Meister EA; Hoying JB
    J Hand Surg Am; 2013 Dec; 38(12):2365-9. PubMed ID: 24140364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts.
    Satish L; Gallo PH; Baratz ME; Johnson S; Kathju S
    BMC Musculoskelet Disord; 2011 May; 12():113. PubMed ID: 21612641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
    Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
    J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren's Contracture.
    Satish L; LaFramboise WA; Johnson S; Vi L; Njarlangattil A; Raykha C; Krill-Burger JM; Gallo PH; O'Gorman DB; Gan BS; Baratz ME; Ehrlich GD; Kathju S
    BMC Med Genomics; 2012 May; 5():15. PubMed ID: 22559715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
    Tomasek J; Rayan GM
    J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased CCT-eta expression is a marker of latent and active disease and a modulator of fibroblast contractility in Dupuytren's contracture.
    Satish L; O'Gorman DB; Johnson S; Raykha C; Gan BS; Wang JH; Kathju S
    Cell Stress Chaperones; 2013 Jul; 18(4):397-404. PubMed ID: 23292503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase inhibition reduces contraction by dupuytren fibroblasts.
    Townley WA; Cambrey AD; Khaw PT; Grobbelaar AO
    J Hand Surg Am; 2008 Nov; 33(9):1608-16. PubMed ID: 18984345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptors in Dupuytren's contracture.
    Pagnotta A; Specchia N; Greco F
    J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biochemistry of Dupuytren's disease.
    Badalamente MA; Hurst LC
    Hand Clin; 1999 Feb; 15(1):35-42, v-vi. PubMed ID: 10050240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transcriptional regulation of alpha-smooth muscle actin determines the contractile phenotype of Dupuytren's nodular cells.
    Verjee LS; Midwood K; Davidson D; Eastwood M; Nanchahal J
    J Cell Physiol; 2010 Sep; 224(3):681-90. PubMed ID: 20432463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP1 Is a Driver of Myofibroblast Differentiation in Normal and Diseased Fibroblasts.
    Piersma B; de Rond S; Werker PM; Boo S; Hinz B; van Beuge MM; Bank RA
    Am J Pathol; 2015 Dec; 185(12):3326-37. PubMed ID: 26458763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dupuytren's disease: comparative growth dynamics and morphology between cultured myofibroblasts (nodule) and fibroblasts (cord).
    Vande Berg JS; Gelberman RH; Rudolph R; Johnson D; Sicurello P
    J Orthop Res; 1984; 2(3):247-56. PubMed ID: 6491814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dupuytren's contracture. Fine structure in relation to aetiology.
    Murrell GA; Francis MJ; Howlett CR
    J Bone Joint Surg Br; 1989 May; 71(3):367-73. PubMed ID: 2722922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
    Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
    J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a novel gene, MafB, in Dupuytren's disease.
    Lee LC; Zhang AY; Chong AK; Pham H; Longaker MT; Chang J
    J Hand Surg Am; 2006 Feb; 31(2):211-8. PubMed ID: 16473681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An insight into Dupuytren's contracture.
    Murrell GA
    Ann R Coll Surg Engl; 1992 May; 74(3):156-60; discussion 161. PubMed ID: 1616255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular structure and biology of Dupuytren's disease.
    Tomasek JJ; Vaughan MB; Haaksma CJ
    Hand Clin; 1999 Feb; 15(1):21-34. PubMed ID: 10050239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and proliferation of cultured fibroblasts from specimens of human palmar fascia and Dupuytren's contracture. The pathobiochemistry of connective tissue proliferation, II.
    Delbrück A; Schröder H
    J Clin Chem Clin Biochem; 1983 Jan; 21(1):11-7. PubMed ID: 6854215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathogenesis of Dupuytren's contracture--a review].
    Koźma EM; Olczyk K; Bobiński R; Kasperczyk M; Szpyra K
    Chir Narzadow Ruchu Ortop Pol; 2002; 67(1):73-9. PubMed ID: 12087679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contractile properties and responses to tensional loading of Dupuytren's disease--derived fibroblasts are altered: a cause of the contracture?
    Bisson MA; Mudera V; McGrouther DA; Grobbelaar AO
    Plast Reconstr Surg; 2004 Feb; 113(2):611-21; discussion 622-4. PubMed ID: 14758224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.